Literature DB >> 1546607

Diagnosis of Sturge-Weber syndrome: comparison of the efficacy of CT and MR imaging in 14 cases.

L Martí-Bonmatí1, F Menor, C Poyatos, H Cortina.   

Abstract

Sturge-Weber syndrome is a neurocutaneous syndrome that includes facial and leptomeningeal angiomas. Imaging findings include cerebral lobar atrophy, brain calcifications, choroid plexus enlargement, cranial diploë prominence, and venous abnormalities. We compared the efficacy of CT and MR imaging in making the diagnosis in 14 consecutive patients. CT, with and without contrast enhancement, was performed in all patients, and 11 of the 14 had MR imaging (eight before and after administration of IV gadopentetate dimeglumine). MR imaging was better than CT in showing the extent and degree of brain parenchymal atrophy, the presumed ischemic changes affecting the gray and white matter, and the cranial diploetic prominence on the affected side. MR imaging after contrast administration permitted a better evaluation of the extent and patency of the leptomeningeal angiomatous malformation and the parenchymal venous anomalies. CT was better than MR imaging in showing the presence and extent of cortical calcifications. Enhanced CT and MR imaging were equal in evaluating the prominence of the ipsilateral choroid plexus. Our experience indicates that contrast-enhanced MR imaging is the method of choice in the diagnosis of Sturge-Weber syndrome. Unenhanced CT should be used only if MR findings are normal, to exclude the presence of intracranial calcifications.

Entities:  

Mesh:

Year:  1992        PMID: 1546607     DOI: 10.2214/ajr.158.4.1546607

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Cortical calcification in Sturge-Weber Syndrome on MRI-SWI: relation to brain perfusion status and seizure severity.

Authors:  Jianlin Wu; Bisher Tarabishy; Jiani Hu; Yanwei Miao; Zhaocheng Cai; Yang Xuan; Michael Behen; Meng Li; Yongquan Ye; Richard Shoskey; E Mark Haacke; Csaba Juhász
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

2.  Sturge-Weber syndrome: Continued vigilance is needed.

Authors:  Saeed Hassan; Amir Babiker; Fahad A Bashiri; Hamdi H Hassan; Maha El Husseini; Mustafa A Salih
Journal:  Sudan J Paediatr       Date:  2015

3.  Sturge-Weber syndrome type III.

Authors:  Devdeep Mukherjee; Ritabrata Kundu; Prabal Chandra Niyogi
Journal:  Indian J Pediatr       Date:  2014-08-27       Impact factor: 1.967

4.  Focal venous hypertension as a pathophysiologic mechanism for tissue hypertrophy, port-wine stains, the Sturge-Weber syndrome, and related disorders: proof of concept with novel hypothesis for underlying etiological cause (an American Ophthalmological Society thesis).

Authors:  Cameron F Parsa
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

5.  Early single photon emission computed tomography in Sturge-Weber syndrome.

Authors:  F Pinton; C Chiron; O Enjolras; J Motte; A Syrota; O Dulac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

Review 6.  The cerebrofacial metameric syndromes: An embryological review and proposal of a novel classification scheme.

Authors:  Anthony S Larson; Waleed Brinjikji; Timo Krings; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-10-19       Impact factor: 1.764

7.  The Sturge-Weber syndrome: correlation between the clinical status and radiological CT and MRI findings.

Authors:  L Martí-Bonmatí; F Menor; F Mulas
Journal:  Childs Nerv Syst       Date:  1993-04       Impact factor: 1.475

8.  Bilateral intracranial calcifications with bilateral facial cutaneous naevus: Sturge Weber syndrome.

Authors:  Muhammad Arif Saeed; Kiran Hilal; Prem Chand
Journal:  BMJ Case Rep       Date:  2017-10-04

9.  A clinician's dilemma: Sturge-Weber syndrome 'without facial nevus'!!

Authors:  Sujit A Jagtap; G Srinivas; Ashalatha Radhakrishnan; K J Harsha
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.